Startup
— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. … Read more
Exploring InfoPathways and their remarkable support of FITCI and the entrepreneurs we serve! This partnership, sparked by a referral, has blossomed into a powerful alliance, showcasing InfoPathways’ unwavering commitment to … Read more
By Anna Eyler In a rapidly evolving business landscape, startups that don’t consider implementing emerging technologies like artificial intelligence (AI) and robotics into their operations are at risk of being … Read more
Experience the Future in Every Dimension at FITCI’s spectacular launch celebration of Maryland’s EDGE at 321 Ballenger Center Drive in Frederick, Maryland. Join the journey into the future of innovation … Read more
FITCI Grad builds upon an unprecedented three Breakthrough Medical Device designations by the FDA Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a … Read more
Budding entrepreneurs and seasoned business leaders gathered at FITCI’s ROOT location in downtown Frederick, Mayrland, for the first installment of the incubator’s newest community program, the IDEA Lab, sponsored by … Read more
CarrTech Corporation performed its human factor trials with local healthcare professionals at FITCI’s Metropolitan Court location May 17th through 28th, moving their all-in-one package filter and hypodermic needle product, F.R.O.G … Read more
Sam Glickstein, CEO of FITCI client Osprey BioScience, announced that the company officially launched their flagship product – CloneCard. The patent-pending item is a proprietary nucleic acid storage and delivery … Read more
